News & Updates
Filter by Specialty:
No level of alcohol intake is safe in MASLD patients, says study
Even modest alcohol consumption is associated with a higher risk of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study.
No level of alcohol intake is safe in MASLD patients, says study
25 Nov 2024
BGF inhaler safe to use in COPD patients
Treatment with budesonide/glycopyrrolate/formoterol (BGF) using a metered dose inhaler (MDI) demonstrates an acceptable safety profile and improves symptoms in patients with chronic obstructive pulmonary disease (COPD) in a real-world clinical setting, results of the TORES study have shown.
BGF inhaler safe to use in COPD patients
25 Nov 2024
Gout remission definition: Does colchicine offer an advantage?
Treatment with colchicine for 6 months when commencing urate-lowering therapy (ULT) provides no additional benefit in achieving gout remission regardless of the definition used, according to a study.
Gout remission definition: Does colchicine offer an advantage?
25 Nov 2024
Depression a costly burden for older adults with chronic diseases in Singapore
In Singapore, depression pushes up healthcare spending by twofold among older adults already struggling with chronic illnesses, according to a study.
Depression a costly burden for older adults with chronic diseases in Singapore
24 Nov 2024
Nirmatrelvir/ritonavir for COVID-19 in children passes safety test
Treatment of symptomatic COVID-19 with nirmatrelvir/ritonavir in children at least 6 years of age who are at risk of progression to severe disease appears to be safe and well-tolerated, with pharmacokinetic data from the open-label phase 2/3 EPIC-Peds* study indicating suitable dosing regimens for two distinct weight categories of this population.
